Recurrence of hepatitis C virus infection after liver transplantation

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 217-221

  Samuel, Didier ^a,b,c   Feray, Cyrille ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

Hepatitis C virus; Liver transplantation; Recurrence

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN; HEPATITIS C ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; TACROLIMUS; VIRUS RNA;

CONFERENCE PAPER; DISEASE COURSE; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION; REINFECTION; VIREMIA;

EID: 0033457330     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80405-x     Document Type: Conference Paper

References (41)

1. Consensus conference on liver transplantation. Hepatology 1994: 20: 1 (suppl).
2. Belle SH, Beringer KC, Detre KM. Recent findings concerning liver transplantation in the United States. In: Terasaki PI, Cecka JM, editors. Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory; 1997. p. 15-30.
3. Bisceglie D. Liver transplantation for hepatitis C: the promise and the challenge. Hepatology 1995: 22: 660-662.
4. Belle SH, Beringer KC, Detre KM. An update on liver transplantation in the United States: recipient characteristics and outcome. Clin Transpl 1995: 1: 19-33.
5. Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992: 89: 1361-1365.
6. Gane E, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT et al. Long-term outcome of hepatitis C virus infection after liver transplantation. N Engl J Med 1996: 334: 815-820.
7. Wright TL, Donegan E, Hsu H, Ferrel L, Lake J, Kim M et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992: 103: 317-322.
8. Chazouillères O, Kirn M, Ferrel L, Robert J, Ascher N, Wilber J et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994: 106: 994-999.
9. Féray C, Gigou M, Samuel D, Paradis V, David MF, Reynes M et al. The course of hepatitis C infection after liver transplantation. Hepatology 1994: 20: 1137-1143.
10. Lim H, Lau G, Davis G, Dolson D, Lau J. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C infection. Gastroenterology 1994: 106: 248-251.
11. Taga SA, Washington MK, Terrault N, Wright TL, Somberg KA, Ferrell LD. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg 1998: 4: 304-310.
12. Chazouillères O, Kim M, Ferrel L, Robert J, Asher N, Wilber J et al. Quantification of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994: 106: 994-999.
13. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998: 28: 823830.
14. Duvoux C, Pawlotsky JM, Cherqui D, Tran van Nhieu J, Metreau JM, Fagniez PL et al. Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection. Transplantation 1995: 15: 60(5): 457-161.
15. Gane EJ, Naoumov NV, Qian KP, Mondelli MU, Maertens G, Portmann BC et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996: 110: 167-177.
16. Di Martino V, Saurini F, Samuel D, Gigou M, Dussaix B, Reynes M et al. Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 1997: 26: 1343-1350.
17. Gretch DR, Bacchi CE, Corey L, delà Rosa C, Lesniewski RR, Kowdley K et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995: 22: 1-9.
18. Féray C, Gigou M, Samuel D, Mishiro S, Reynes M, Bismuth H et al. Influence of the genotypes on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995: 108: 10S9-1097.
19. Zein NN, Rakela J, Poterucha JJ, Steers JL, Wiesner RH, Persing DH. Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up. Liver Transplant Surg 1995: 1: 354357.
20. Pageaux GP, Ducos J, Mondain AM, Costes V, Picot MC, Perrigault PF et al. Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection. Liver Transplant Surg 1997: 3: 501-5o"5.
21. Shuhart M, Bronner M, Gretch D, Thomassen L, Wartelle C, Tateyama H et al. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 1997: 26: 16461652.
22. Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB Jr et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997: 27;63: 1419-1423.
23. Costes V, Durand L, Pageaux GP, Ducos J, Mondain AM, Picot MC et al. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologie outcome of recurrent hepatitis C. Am J Clin Pathol 1999: 111: 252-258.
24. Berg T, Hopf U, Bechstein WO, Muller AR, Fukumoto T, Neuhaus R et al. Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantation. Transplantation 1998: 27: 66: 225-228.
25. Vargas HE, Laskus T, Wang LF, Radkowski M, Poutous A, Lee R et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transplant Surg 1998:4:22-27.
26. Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997: 25: 203-210.
27. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996: 24: 1041-1046.
28. Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D et al. High incidence of allograft cirrhosis in hepatitis C virus genotype Ib infection following transplantation: relationship with rejection episodes. Hepatology 1999: 29: 250-256.
29. Sullivan DG, Wilson JJ, Carithers RL Jr, Perkins JD, Gretch DR. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 1997: 72: 10036-10043.
30. Yun Z, Barkholt L, Sonnerborg A. Dynamic analysis of hepatitis C virus polymorphism in patients with orthotopic liver transplantation. Transplantation 1997: 15: 64: 170-172.
31. Martell M, Esteban JI, Quer J, Vargas V, Esteban R, Guardia J et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994: 68: 3425-3436.
32. Coller SJ, Gaur LK, Gretch DR, Wile M, Strong DM, Bronner MP et al. Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens 1998: 52: 435-443.
33. Charco R, Vargas V, Allende H, Edo A, Balsells J, Murio E et al. Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection? Transplant Int 1996: 9 Suppl 1: S195-197.
34. Rozen HR, Shackleton CR, Higa L, Gralnek IM, Farmer D, Me Diarmid SV et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997: 92: 14453-14457.
35. Rosen HR, Martin P. OKT3 and hepatitis C: defining the risks. Transplantation 1997: 15: 171-172.
36. Zervos XA, Weppler D, Fragulidis GP, Torres MB, Nery JR, Khan MF et al. Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. Transplantation 1998: 27: 65: 1044-1046.
37. Caccamo L, Colledan M, Rossi G, Gridelli B, Maggi U, Vannelli A et al. Post-hepatitis primary disease does not influence 6-year survival after liver transplantation beyond 1 year. Transplant Int 1998: 11 Suppl 1:5212-220.
38. Prieto M, Berenguer M, Rimola A, Loinaz C, Barrios C, Clé mente G et al. Liver transplantation in hepatitis C. A Spanish multi-centre experience. Eur J Gastroenterol Hepatol 1998: 10: 771-776.
39. Rosen HR, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998: 27/66: 16121616
40. Sheiner PA, Schluger LK, Emre S, Thung SN, Lau JY, Guy SR et al. Retransplantation for recurrent hepatitis C. Liver Transplant Surg 1997: 3: 130-136.
41. European Liver Transplant Registry: update 12/1997, Hôpital Paul Brousse, Villejuif, France.